Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine (NEJM) highlighting the development and potential benefits of the company's S-ICD® ...
Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...
SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...